Rocuronium: Clinical Trials

6 trials for Rocuronium, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 unknown, 1 not yet recruiting, 1 recruiting. 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 46Completed 2, Unknown 2, Not yet recruiting 1, Recruiting 1

Follow Rocuronium: new trials by email Literature Review of Rocuronium trials Research Report on Rocuronium

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Developing a Physiology-Pharmacodynamic Model of Rocuronium Dose and Cardiac Output to Investigate the Onset Time of Neuromuscular Relaxation
Rocuronium dosing - Induction of Anaesthesia, Muscle Relaxants
Phase 4Not yet recruitingClare Hayes-Bradley322025-12-012025-11-25
Remifentanil Versus Rocuronium for Optimizing Video Laryngoscopy-assisted Tracheal Intubation
Remifentanil, Rocuronium - Tracheal Intubation, Video Laryngoscopy
Phase 4RecruitingNordsjaellands Hospital26842025-11-172026-09-21
Diaphragm Ultrasound to Evaluate the Antagonistic Effect of Sugammadex
sugammadex - Diaphragm Ultrasonography, Liver Dysfunction
Phase 4UnknownUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology992021-07-012021-09-05
General Anesthesia With and Without Muscle Relaxation and Muscle Strength Recovery
Rocuronium, General anesthesia for surgery - Rocuronium, Muscle Weakness
Phase 4CompletedClinical Hospital Centre Zagreb602020-04-012026-01-21
Effect of Pre-treatment With Magnesium Sulfate on the Duration of Deep Neuromuscular Blockade With Rocuronium
Sulfate, Magnesium, saline group - Magnesium Sulfate, Neuromuscular Blockade
Phase 4UnknownHospital Federal de Bonsucesso602016-12-012016-12-12
Residual Paralysis and Reversal With Routine Neostigmine Versus Half-dose Sugammadex and Routine Neostigmine
Neostigmine, Sugammadex - Neuromuscular Blockade, Sugammadex
Phase 4CompletedKartal Kosuyolu Yuksek Ihtisas Education and Research Hospital1132013-05-012021-10-04

Narrower conditions

Delayed Emergence from Anesthesia (1)  ·  Liver Diseases (1)  ·  Muscle Hypotonia (1)  ·  Muscle Weakness (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (3)  ·  Nervous System Diseases (2)  ·  Neurologic Manifestations (2)  ·  Neuromuscular Manifestations (2)  ·  Pathologic Processes (2)  ·  Signs and Symptoms (2)  ·  Digestive System Diseases (1)  ·  Muscular Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Postoperative Complications (1)

Interventions

Rocuronium (2)  ·  Sugammadex (2)  ·  Anesthesia, General (1)  ·  Magnesium Sulfate (1)  ·  Neostigmine (1)  ·  Remifentanil (1)  ·  Sodium Chloride (1)  ·  Surgical Procedures, Operative (1)

Sponsors

Clare Hayes-Bradley (1)  ·  Clinical Hospital Centre Zagreb (1)  ·  Hospital Federal de Bonsucesso (1)  ·  Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital (1)  ·  Nordsjaellands Hospital (1)  ·  Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1)

Countries

Brazil (1)  ·  China (1)  ·  Croatia (1)  ·  Denmark (1)

Top investigators

Ismar L Cavalcanti, master (1)  ·  Matias Vested, PhD (1)  ·  Nubia V Figueiredo, master (1)  ·  Yun Lin, MD, PhD. (1)

Results publications

PMID 20876699, PMID 20885293, PMID 26634077, PMID 28399799, PMID 30985540, PMID 35105573, PMID 38686365, PMID 42304626

NIH funding

2025 (1)